Your browser doesn't support javascript.
loading
Successful treatment of advanced gastric cancer with liver metastasis by S-1 + CDDP and S-1 therapy without surgery.
Tanishima, Yuichiro; Nyumura, Yuya; Nakayoshi, Tomoko; Hoya, Yoshiyuki; Okamoto, Tomoyoshi; Yanaga, Katsuhiko.
Afiliação
  • Tanishima Y; 1Department of Surgery, The Jikei University Daisan Hospital, Tokyo, Japan.
  • Nyumura Y; 2Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Nakayoshi T; 1Department of Surgery, The Jikei University Daisan Hospital, Tokyo, Japan.
  • Hoya Y; 2Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Okamoto T; 1Department of Surgery, The Jikei University Daisan Hospital, Tokyo, Japan.
  • Yanaga K; 2Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
Int Cancer Conf J ; 8(3): 101-104, 2019 Jul.
Article em En | MEDLINE | ID: mdl-31218183
ABSTRACT
It is generally reported that prognosis of patients who have unresectable gastric cancer is from 3 to 5 months with best supportive care. Despite the improvement of survival after the appearance of S-1, the outcome of treatment for advanced gastric cancer is still unfavorable. Here we present a valuable case of advanced gastric cancer with synchronous liver metastasis, which was treated by S-1 + CDDP and S-1 therapy without surgery. A 58-year-old man was referred to our hospital with a diagnosis of advanced gastric cancer with liver metastasis at stage of cT3N0M1. He underwent first-line chemotherapy consisting of S-1 plus cispatin. 3 months later, a follow-up endoscopy revealed complete response (CR) of the gastric lesion. 3 months later, computed tomography (CT) also demonstrated disappearance of liver metastasis. Then he underwent maintenance chemotherapy with S-1 alone for 8 months. To date, there has been no recurrence for 6 years and 6 months since the acquisition of CR.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Int Cancer Conf J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Int Cancer Conf J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão